GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Health Assurance Acquisition Corp (NAS:HAACU) » Definitions » ROE %

Health Assurance Acquisition (Health Assurance Acquisition) ROE % : 7.50% (As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Health Assurance Acquisition ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Health Assurance Acquisition's annualized net income for the quarter that ended in Jun. 2022 was $37.11 Mil. Health Assurance Acquisition's average Total Stockholders Equity over the quarter that ended in Jun. 2022 was $494.54 Mil. Therefore, Health Assurance Acquisition's annualized ROE % for the quarter that ended in Jun. 2022 was 7.50%.

The historical rank and industry rank for Health Assurance Acquisition's ROE % or its related term are showing as below:

HAACU' s ROE % Range Over the Past 10 Years
Min: 8.55   Med: 10.15   Max: 10.15
Current: 8.55

During the past 2 years, Health Assurance Acquisition's highest ROE % was 10.15%. The lowest was 8.55%. And the median was 10.15%.

HAACU's ROE % is not ranked
in the Diversified Financial Services industry.
Industry Median: 0.53 vs HAACU: 8.55

Health Assurance Acquisition ROE % Historical Data

The historical data trend for Health Assurance Acquisition's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Health Assurance Acquisition ROE % Chart

Health Assurance Acquisition Annual Data
Trend Dec20 Dec21
ROE %
- 10.15

Health Assurance Acquisition Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
ROE % Get a 7-Day Free Trial 21.94 17.96 2.77 6.24 7.50

Competitive Comparison of Health Assurance Acquisition's ROE %

For the Shell Companies subindustry, Health Assurance Acquisition's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Health Assurance Acquisition's ROE % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Health Assurance Acquisition's ROE % distribution charts can be found below:

* The bar in red indicates where Health Assurance Acquisition's ROE % falls into.



Health Assurance Acquisition ROE % Calculation

Health Assurance Acquisition's annualized ROE % for the fiscal year that ended in Dec. 2021 is calculated as

ROE %=Net Income (A: Dec. 2021 )/( (Total Stockholders Equity (A: Dec. 2020 )+Total Stockholders Equity (A: Dec. 2021 ))/ count )
=46.608/( (435.706+482.314)/ 2 )
=46.608/459.01
=10.15 %

Health Assurance Acquisition's annualized ROE % for the quarter that ended in Jun. 2022 is calculated as

ROE %=Net Income (Q: Jun. 2022 )/( (Total Stockholders Equity (Q: Mar. 2022 )+Total Stockholders Equity (Q: Jun. 2022 ))/ count )
=37.112/( (489.896+499.174)/ 2 )
=37.112/494.535
=7.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jun. 2022) net income data. ROE % is displayed in the 30-year financial page.


Health Assurance Acquisition  (NAS:HAACU) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jun. 2022 )
=Net Income/Total Stockholders Equity
=37.112/494.535
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(37.112 / 0)*(0 / 526.343)*(526.343 / 494.535)
=Net Margin %*Asset Turnover*Equity Multiplier
=N/A %*0*1.0643
=ROA %*Equity Multiplier
=N/A %*1.0643
=7.50 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jun. 2022 )
=Net Income/Total Stockholders Equity
=37.112/494.535
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (37.112 / 37.312) * (37.312 / -1.532) * (-1.532 / 0) * (0 / 526.343) * (526.343 / 494.535)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9946 * -24.3551 * N/A % * 0 * 1.0643
=7.50 %

Note: The net income data used here is four times the quarterly (Jun. 2022) net income data. The Revenue data used here is four times the quarterly (Jun. 2022) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Health Assurance Acquisition ROE % Related Terms

Thank you for viewing the detailed overview of Health Assurance Acquisition's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Health Assurance Acquisition (Health Assurance Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
20 University Road, Cambridge, MA, USA, 02138
Health Assurance Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
Executives
Atlas Merchant Capital Llc 10 percent owner 477 MADISON AVENUE, 22ND FLOOR, NEW YORK NY 10022
Mark Joseph Allen officer: Chief Financial Officer 20 UNIVERSITY ROAD, CAMBRIDGE MA 02138
Michelle A Brown officer: Chief Financial Officer C/O HEALTH ASSURANCE ACQUISITION CORP., 20 UNIVERSITY ROAD, CAMBRIDGE MA 02138
Klasko Stephen K. M.d. director 155 SOUTH LIMERICK ROAD, LIMERICK PA 19468
Anita Pramoda director 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Glen Tullman director C/O LIVONGO HEALTH, INC., 150 WEST EVELYN AVENUE, SUITE 150, MOUNTAIN VIEW CA 94041
Quentin Clark director 333 BRANNAN STREET, SAN FRANCISCO CA 94107
Hemant Taneja director, officer: Chief Executive Officer C/O GENERAL CATALYST, 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
Jennifer Schneider director C/O LIVONGO HEALTH, INC., 150 WEST EVELYN AVENUE, SUITE 150, MOUNTAIN VIEW CA 94041
Evan Sotiriou officer: Chief Operating Officer C/O HEALTHCARE ASSURANCE ACQUISITION, 20 UNIVERSITY ROAD, FOURTH FLOOR, CAMBRIDGE MA 02138
Health Assurance Economy Foundation 10 percent owner 20 UNIVERSITY ROAD, FOURTH FLOOR, CAMBRIDGE MA 02138
Haac Sponsor, Llc 10 percent owner C/O GENERAL CATALYST, 20 UNIVERSITY ROAD, FOURTH FLOOR, CAMBRIDGE MA 02138